Thematische Bibliographien / Cancer prevention center

Inhaltsverzeichnis

  1. Zeitschriftenartikel
  2. Dissertationen
  3. Bücher
  4. Buchteile
  5. Konferenzberichte
  6. Berichte der Organisationen

Auswahl der wissenschaftlichen Literatur zum Thema „Cancer prevention center“

Autor: Grafiati
Veröffentlicht am 28. Juni 2021
Zuletzt aktualisiert am 1. Februar 2022

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Cancer prevention center" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Cancer prevention center"

1

Thom, K. A., M. Kleinberg und M. C. Roghmann. „Infection Prevention in the Cancer Center“. Clinical Infectious Diseases 57, Nr. 4 (07.05.2013): 579–85. http://dx.doi.org/10.1093/cid/cit290.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Granwehr, Bruno Palma, Kelly W. Merriman, Zeena Shelal, Hadil Bazerbashi, Patricia A. Brock, Carmen E. Gonzalez, Harrys A. Torres und Terry Rice. „HIV-testing in a cancer center emergency department.“ Journal of Clinical Oncology 34, Nr. 7_suppl (01.03.2016): 225. http://dx.doi.org/10.1200/jco.2016.34.7_suppl.225.

Der volle Inhalt der Quelle
Annotation:
225 Background: HIV is a cancer-associated virus classically associated with KS, NHL, and cervical cancer, but more recently with anal cancer, lung, and head and neck cancers. HIV testing and treatment are important for cancer patients for three reasons: 1) HIV treatment is associated with reduced transmission of a cancer-associated virus. 2) HIV treatment is associated with improved outcomes of cancer therapy in many cancers. 3) HIV testing optimizes quality of care, since testing is recommended by the Centers for Disease Control and Prevention (CDC) and the US Preventive Services Task Force (USPSTF)(A level recommendation) for patients between the ages of 15 and 65 years of age. Since emergency centers (EC’s) commonly provide immunizations and other preventive care, we implemented HIV testing at our cancer center EC. Methods: In our 44 bed cancer center EC with approximately 25,000 annual visits, routine implementation by physician order was implemented in July 2014. EC information technology (IT) assisted in modification of the order sets and facilitated documentation of specific consent for HIV. Educational materials were disseminated to patients and EC providers. A new consent form with integration of HIV consent, including a check box to refuse HIV testing, was implemented on June 19, 2015. Testing results are described through August 2015. Results: HIV testing increased significantly from July 2014 and August 2015. The impact on institutional testing was considerable, increasing from 1.2% of all HIV testing in 2013 to 15.1% to date in 2015. Between July 2014 and August 2015, 1.4% (0.4% incident) of 852 patients screened positive for HIV. Notably, 83% of patients agreed to HIV testing, but less than 20% of patients were actually tested. The highest refusal rate (18.8%) was in patients over age 70 and lowest (9.9%) in those 21-29 years of age. Conclusions: Routine HIV testing is feasible in a comprehensive cancer center ED, but increased awareness is necessary to optimize testing, given the high acceptance rate. Seroprevalence of HIV is comparable to non-cancer center EC’s (0.5-1.2%). These results demonstrate the acceptance by patients of testing for HIV, with implications in reduction of transmission of this cancer-associated virus.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Vogel, Victor. „A clinical cancer prevention curriculum in a comprehensive cancer center“. Journal of Cancer Education 6, Nr. 3 (1991): 133–39. http://dx.doi.org/10.1080/08858199109528109.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Tarallo, Phyllis A. „Developing a Women's Health Cancer Prevention Program in a Liver Transplant Center“. Clinical Scholars Review 5, Nr. 1 (April 2012): 39–42. http://dx.doi.org/10.1891/1939-2095.5.1.39.

Der volle Inhalt der Quelle
Annotation:
Human papillomavirus (HPV) has been detected in 90% of cervical cancers. Cervical cancer is the fourth most common cancer found in women in developed countries and the second most common in underdeveloped countries. People that undergo organ transplant have a high risk of developing other malignancies, depending on the duration and strength of immunosuppressive therapy. This article presents development and implementation of a women's health cancer prevention program in a liver transplant center.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Bernstein, Ezra, Ofer Isakov, Lior Galazan, Ari Leshno, Meital Shaked, Eliezer Liberman, Eyal Gur et al. „Data from an integrated cancer prevention center screening for multiple cancer types.“ Journal of Clinical Oncology 37, Nr. 15_suppl (20.05.2019): e13069-e13069. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e13069.

Der volle Inhalt der Quelle
Annotation:
e13069 Background: Cancer is the second leading cause of death globally, and was responsible for ~9.6 million deaths in 2018. Importantly, between 30–50% of cancers can be prevented by avoiding risk factors and implementing existing evidence-based prevention strategies. Methods: We present the results of 15758 adults who came to our clinic between 2006 and 2018. Patients were counseled on reducing risk factors and screened for early detection of 11 of the most common cancer types. Patients were examined by specialists in internal medicine, surgery, plastic surgery, OBGYN, urology, oncology, oral surgery, gastroenterology, and others. Women underwent vaginal US, pap smear, mammography (40yr) and US/MRI of the breast with a clinical indication. Men underwent PSA/free PSA ( > 40yr). LDCT for moderate smokers. Colonoscopy was recommended to all subjects ( > 40yr). Results: A total of 7900 (50.1%) men and 7857 women (49.9%) mean age 46.9±11.3 years were screened. A total of 418 (2.7%) malignant lesions were detected in patients who had been screened, 245 (1.6%) of which were detected through our screening: skin 66 (0.4%), prostate 30 (0.2%), thyroid 28 (0.2%), breast 28 (0.2%), colorectal 19 (0.1%), urinary 13 (0.08%), lung 11 (0.07%), cervical 11 (0.07%), other/unknown 9 (0.06%), hematologic 8 (0.05%), ovarian 5 (0.03%), uterine 5 (0.03%), pancreas 3 (0.02%), testicular 3 (0.02%), oropharyngeal 2 (0.01%), hepatobiliary 2 (0.01%), stomach 1 (0.01%), larynx 1 (0.01%). A total of 17 (0.1%) malignant lesions were missed: breast 3 (0.02%), colorectal 3 (0.02%), skin 2 (0.01%), thyroid 2 (0.01%), hematologic 2 (0.01%), pancreas 2 (0.01%), kidney 1 (0.01%), lung 1 (0.01%), brain 1 (0.01%). A total of 147 (0.9%) malignant lesions developed > 1year after a visit. Only forty-nine of the cancer patients (12.5%) died after 18.9±17.8 months at a mean age of 66.5±12.2 years. Significantly, better than the expected cancer mortality in general. First-degree family member with cancer (HR = 1.46) and advanced age (HR = 21.8) was associated with increased cancer risk (P < 0.05). Conclusions: One stop shop cancer screening, in the setting of a multidisciplinary outpatient clinic is feasible, can detect cancer at an early stage, and can significantly improve survival.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Lopez, Ana Maria, Jennyffer Morales, Garrett Harding und Donna Branson. „Utilizing social media for cancer prevention.“ Journal of Clinical Oncology 37, Nr. 15_suppl (20.05.2019): e13076-e13076. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e13076.

Der volle Inhalt der Quelle
Annotation:
e13076 Background: Cancer prevention and cancer screening behaviors are challenging to support. A myriad of variables including improved knowledge, language access, and health care access serve as facilitators for cancer screening behaviors. Utah is a vast state that is remarkably sparsely populated with more than 96% of the state defined as either rural (< 100 persons per square mile) or frontier (< 7 persons per square mile). Huntsman Cancer Institute is the only academic health center in the Mountain West and serves as the only NCI Comprehensive Cancer Center in the region. Methods: Access to the internet and to social media helps to bridge geography and support engagement. Facebook Live and Twitter Chats were used to deliver content. Language, Spanish, access was considered. Social media was also utilized to connect interested populations with in-person cancer prevention education events. Results: We will present our outreach results by intervention. Conclusions: Our work has successfully engaged rural and Latino populations in cancer prevention activities through social media.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Dewald, Lori L. „Cancer Education and Prevention in the Athletic Training Center“. Athletic Therapy Today 7, Nr. 1 (Januar 2002): 16–19. http://dx.doi.org/10.1123/att.7.1.16.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Schweitzer, Robert J. „A cancer education and prevention center a community program“. Cancer 62, S1 (15.10.1988): 1821–22. http://dx.doi.org/10.1002/1097-0142(19881015)62:1+<1821::aid-cncr2820621323>3.0.co;2-d.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Wolf, Ido, Ari Leshno, Eliezer Liberman, Eyal Gur, Hanoch Elran, Miri Sror, Amira Harlap-Gat et al. „Ten year experience of an integrated cancer prevention center screening for multiple cancer types.“ Journal of Clinical Oncology 35, Nr. 15_suppl (20.05.2017): 1549. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1549.

Der volle Inhalt der Quelle
Annotation:
1549 Background: Cancer is the leading cause of mortality worldwide. Prevention and early detection are pivotal tools for reducing cancer burden. Methods: We describe the 10 year experience (2006-2016) of an integrated cancer prevention center that provides screening for prevention and early detection of 11 most common cancer types. Healthy individuals (20-80 yr) were included. Extensive clinical and epidemiological data was obtained. DNA was extracted from all participants and genotyped for APC I1307K and E1317Q. Patients were examined by specialists in internal medicine, surgery, plastic surgery, OBGYN, urology, oncology, oral surgery, gastroenterology, and others. Women underwent vaginal US and pap smear and (40yr) mammography and US/MRI with a clinical indication. PSA and free PSA for Men ( > 40yr). LDCT for heavy smokers. Colonoscopy was recommended to all subjects ( > 40yr). Results: A total of 6258 (49%) men and 6461 (51%) women mean age 47.0±11.5 year were screened. New malignant lesions were detected in 389 (1.75%) of screeners. The most common cancers were of skin (74, 0.6%), prostate (62, 0.5%), thyroid (51, 0.4%), breast (36, 0.3%), colorectal (22, 0.2%), ovarian (19, 0.1%), uterus (14, 0.1%), testis (12, 0.09%) urinary (9, 0.07%) and lung (10, 0.08%). In 28 patients (0.22%) more than one cancer was detected. Twenty eight of the cancer patients (7.2%) died after 32.4±28.1 months at a mean age of 69.4±14.2 years. Significantly, better than the expected cancer mortality. The APC I1307K and E1317Q variants were detected in 572 (4.8%) and 182 (1.5%) subjects respectively. First degree family member with cancer (OR = 2.02), I1307K carrier ship (OR = 1.53), female gender (OR = 1.23) and advanced age (OR = 1.06) were all associated with statistically significant (P < 0.05) increased cancer risk. Advanced age and first degree family history were also associated with detection of more than one cancer types. Conclusions: One stop shop screening, in the setting of a multidisciplinary outpatient clinic, is feasible and can prevent and detect cancer at an early stage. It significantly improve morbidity and mortality. Impressively the APC I1307K carries an overall increase cancer risk.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Meyskens, F. L. „Evolution of Cancer Prevention and Control Program at The Arizona Cancer Center“. JNCI Journal of the National Cancer Institute 80, Nr. 20 (21.12.1988): 1595–98. http://dx.doi.org/10.1093/jnci/80.20.1595.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Dissertationen zum Thema "Cancer prevention center"

1

Brooks, Billy, David Blackley und Megan Quinn. „Appalachian Environmental Cancer Communication Workshop“. Digital Commons @ East Tennessee State University, 2011. https://dc.etsu.edu/etsu-works/3193.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

LACLAVERIE, JEAN-LOUIS. „Experience d'un centre de depistage et de prevention des cancers colo-rectaux“. Toulouse 3, 1989. http://www.theses.fr/1989TOU31214.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Boehm, Jennifer E. „Understanding Program Start-Up: Two Cases from the Centers for Disease Control and Prevention’s Colorectal Cancer Screening Demonstration Program“. Digital Archive @ GSU, 2007. http://digitalarchive.gsu.edu/iph_theses/24.

Der volle Inhalt der Quelle
Annotation:
Colorectal cancer poses a serious threat to the health and well-being of individuals, especially those at high risk or over the age of 50. Gone undetected, colorectal cancer is often fatal, however, preventive screening greatly reduces the number of people who may develop this disease. The Centers for Disease Control and Prevention developed the Colorectal Cancer Screening Demonstration Program in 2005 to assess the feasibility of a national colorectal cancer screening program serving low-income and un- or underinsured populations. Qualitative case study data from the Colorectal Cancer Screening Demonstration Program evaluation were analyzed in order to examine the start-up experiences of two of the programs involved. Results from this multiple case study document program models and describe facilitators, challenges, and participant perception of the expected impact on screening behavior. Further research on program implementation is needed to understand how program models perform and impact behavior once screening begins.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Boehm, Jennifer E. „Understanding program start-up two cases from the Centers for Disease Control and Prevention's Colorectal Cancer Screening Demonstration Program /“. mixed, 2007. http://etd.gsu.edu/theses/available/etd-11272007-140951/.

Der volle Inhalt der Quelle
Annotation:
Thesis (M.P.H.)--Georgia State University, 2007.
Title from file title page. Michael P. Eriksen, committee chair; Marshall W. Kreuter, Amy DeGroff, committee members. Electronic text (145 p. : ill. (some col.)) : digital, PDF file. Description based on contents viewed May 23, 2008. Includes bibliographical references (p. 96-104).
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Morgan, Chodaesessie Wellesley-Cole. „Cervical Cancer Screening Disparities in an Ethnically Diverse Population of Women Residing in the United States in 1999: A Secondary Analysis of Data from the 1999 Behavioral Risk Factor Surveillance System“. [Tampa, Fla.] : University of South Florida, 2005. http://purl.fcla.edu/fcla/etd/SFE0001202.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Reynolds, Terrianne Lynn. „Validation of knowledge of CDC skin cancer prevention protocol in a mid-western town“. 2002. http://www.oregonpdf.org.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Carney, Timothy Jay. „An Organizational Informatics Analysis of Colorectal, Breast, and Cervical Cancer Screening Clinical Decision Support and Information Systems within Community Health Centers“. Thesis, 2013. http://hdl.handle.net/1805/3243.

Der volle Inhalt der Quelle
Annotation:
Indiana University-Purdue University Indianapolis (IUPUI)
A study design has been developed that employs a dual modeling approach to identify factors associated with facility-level cancer screening improvement and how this is mediated by the use of clinical decision support. This dual modeling approach combines principles of (1) Health Informatics, (2) Cancer Prevention and Control, (3) Health Services Research, and (4) Organizational Change/Theory. The study design builds upon the constructs of a conceptual framework developed by Jane Zapka, namely, (1) organizational and/or practice settings, (2) provider characteristics, and (3) patient population characteristics. These constructs have been operationalized as measures in a 2005 HRSA/NCI Health Disparities Cancer Collaborative inventory of 44 community health centers. The first, statistical models will use: sequential, multivariable regression models to test for the organizational determinants that may account for the presence and intensity-of-use of clinical decision support (CDS) and information systems (IS) within community health centers for use in colorectal, breast, and cervical cancer screening. A subsequent test will assess the impact of CDS/IS on provider reported cancer screening improvement rates. The second, computational models will use a multi-agent model of network evolution called CONSTRUCT® to identify the agents, tasks, knowledge, groups, and beliefs associated with cancer screening practices and CDS/IS use to inform both CDS/IS implementation and cancer screening intervention strategies. This virtual experiment will facilitate hypothesis-generation through computer simulation exercises. The outcome of this research will be to identify barriers and facilitators to improving community health center facility-level cancer screening performance using CDS/IS as an agent of change. Stakeholders for this work include both national and local community health center IT leadership, as well as clinical managers deploying IT strategies to improve cancer screening among vulnerable patient populations.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bücher zum Thema "Cancer prevention center"

1

Michael, Osborne, Oliveria Susan und Pepin Jacques (trans ), Hrsg. The strang cancer center prevention cookbook. New York: McGraw-Hill, 2004.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

United States. President's Cancer Panel. Meeting. President's Cancer Panel Meeting: Cancer prevention and control research in the 21st century : Arizona Cancer Center, Kiewit Auditorium, Tucson, Arizona, November 17, 1998. Bethesda, Md.]: National Cancer Institute, 1999.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Reauthorization of the CDC breast and cervical cancer mortality prevention program: Hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Third Congress, first session, on examining proposed legislation to authorize funds for the Center for Disease Control's breast and cervical cancer mortality prevention program July 15, 1993. Washington: U.S. G.P.O., 1993.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

United States. President's Cancer Panel. Meeting. President's Cancer Panel Meeting: Transcript of proceedings, February 1-2, 2001 : Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. [Bethesda, Md: National Cancer Institute, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

1936-, Engstrom Paul F., Mortenson Lee E, Anderson Paul N, Association of Community Cancer Centers., Association of American Cancer Institutes. und Association of Community Cancer Centers. Meeting, Hrsg. Advances in cancer control: The war on cancer, 15 years of progress : proceedings of the Fourth Annual Meeting on Advances in Cancer Control : a combined meeting of the Association of Community Cancer Centers/Association of American Cancer Institutes, held in Washington, D.C., April 2-6, 1986. New York: Liss, 1987.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

From pink to green: Disease prevention and the environmental breast cancer movement. New Brunswick, N.J: Rutgers University Press, 2009.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Third opinion: An international directory to alternative therapy centers for the treatment and prevention of cancer. Garden City Park, N.Y: Avery Pub. Group, 1988.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Meeting on Advances in Cancer Control (5th 1987 Washington, D.C.). Advances in cancer control: Cancer control research and the emergence of the oncology product line : proceedings of the Fifth Annual Meeting on Advances in Cancer Control--a combined meeting of the Association of Community Cancer Centers/Association of American Cancer Institutes, held in Washington, D.C., March 11-15, 1987. Herausgegeben von Engstrom Paul F. 1936-, Anderson Paul N, Mortenson Lee E, Association of Community Cancer Centers. und Association of American Cancer Institutes. New York: Liss, 1988.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

N, Anderson Paul, Engstrom Paul F. 1936-, Mortenson Lee E, Association of Community Cancer Centers. und Association of American Cancer Institutes., Hrsg. Advances in cancer control: Innovations and research : proceedings of the Sixth Annual Meeting on Advances in Cancer Control--a combined Meeting of the Association of Community Cancer Centers/ Association of American Cancer Institutes, held in Washington, D.C., March 15-16, 1988. New York: Liss, 1989.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Robert, Proctor. The Nazi war on cancer. Princeton, N.J: Princeton University Press, 1999.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Buchteile zum Thema "Cancer prevention center"

1

Leblond, Véronique, Richard Dorent, Marc-Olivier Bitker, Carole Soussain, Didier Samuel, Jacques-Louis Binet und Martine Raphael. „Therapeutic issues in lymphoproliferative disorders: Treatment and outcome of 28 cases observed in a single center“. In Cancer in Transplantation: Prevention and Treatment, 267–78. Dordrecht: Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-0175-9_30.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Igna, D., H. Keller und G. Kirste. „The Incidence of Malignancy in the Population of 1.280 Kidney Transplantations - A Complete Single Center Analysis“. In Cancer in Transplantation: Prevention and Treatment, 335. Dordrecht: Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-009-0175-9_51.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Tajima, Kazuo, Kaoru Hirose, Manami Inoue, Toshiro Takezaki und Nobuyuki Hamajima. „Exercise and Cancer Prevention: Study from Hospital-Based Epidemiologic Research Program at Aichi Cancer Center (HERPACC)“. In Exercise for Preventing Common Diseases, 98–108. Tokyo: Springer Japan, 1999. http://dx.doi.org/10.1007/978-4-431-68511-1_12.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Tewari, Krishnansu, und Bradley Monk. „Screening and prevention of ovarian cancer“. In The 21st Century Handbook of Clinical Ovarian Cancer, 11–19. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-08066-6_2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Zhang, Cissy, und Anne Le. „Diabetes and Cancer: The Epidemiological and Metabolic Associations“. In The Heterogeneity of Cancer Metabolism, 217–27. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_16.

Der volle Inhalt der Quelle
Annotation:
AbstractDiabetes mellitus, commonly known as diabetes, and cancer are two of the most common diseases plaguing the world today. According to the Centers for Disease Control and Prevention (CDC), there are currently more than 20 million people with diabetes in the United States [1]. According to the International Agency for Research on Cancer (IARC), there were around 18 million people diagnosed with cancer, with approximately ten million deaths globally in 2018 [2]. Given the prevalence and deadliness of diabetes and cancer, these two diseases have long been the focus of many researchers with the goal of improving treatment outcomes. While diabetes and cancer may seem to be two very different diseases at first glance, they share several similarities, especially regarding their metabolic characteristics. This chapter discusses the similarities and relationships between the metabolism of diabetes, especially type 2 diabetes (T2D), and cancer, including their abnormal glucose and amino acid metabolism, the contribution of hyperglycemia to oncogenic mutation, and the contribution of hyperinsulinemia to cancer progression. Investigating the metabolic interplay between diabetes and cancer in an effort to exploit this connection for cancer treatment has the potential to significantly improve clinical efficacy.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Carney, Timothy Jay, Michael Weaver, Anna M. McDaniel, Josette Jones und David A. Haggstrom. „Organizational Factors Influencing the Use of Clinical Decision Support for Improving Cancer Screening Within Community Health Centers“. In E-Health and Telemedicine, 118–48. IGI Global, 2016. http://dx.doi.org/10.4018/978-1-4666-8756-1.ch007.

Der volle Inhalt der Quelle
Annotation:
Adoption of clinical decision support (CDS) systems leads to improved clinical performance through improved clinician decision making, adherence to evidence-based guidelines, medical error reduction, and more efficient information transfer and to reduction in health care disparities in under-resourced settings. However, little information on CDS use in the community health care (CHC) setting exists. This study examines if organizational, provider, or patient level factors can successfully predict the level of CDS use in the CHC setting with regard to breast, cervical, and colorectal cancer screening. This study relied upon 37 summary measures obtained from the 2005 Cancer Health Disparities Collaborative (HDCC) national survey of 44 randomly selected community health centers. A multi-level framework was designed that employed an all-subsets linear regression to discover relationships between organizational/practice setting, provider, and patient characteristics and the outcome variable, a composite measure of community health center CDS intensity-of-use. Several organizational and provider level factors from our conceptual model were identified to be positively associated with CDS level of use in community health centers. The level of CDS use (e.g., computerized reminders, provider prompts at point-of-care) in support of breast, cervical, and colorectal cancer screening rate improvement in vulnerable populations is determined by both organizational/practice setting and provider factors. Such insights can better facilitate the increased uptake of CDS in CHCs that allows for improved patient tracking, disease management, and early detection in cancer prevention and control within vulnerable populations.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Cross, Amanda J., Johanna W. Lampe, Cheryl L. Rock und Carol J. Boushey. „Biomarkers and Their Use in Nutrition Intervention * *This chapter was updated from the previous edition by Gerald Corpuz, University of Hawaii Cancer Center CURE intern, under the supervision of Carol J. Boushey, Co-Editor.“ In Nutrition in the Prevention and Treatment of Disease, 217–34. Elsevier, 2017. http://dx.doi.org/10.1016/b978-0-12-802928-2.00011-4.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Freudenberg, Nicholas. „Healthcare“. In At What Cost, 124–52. Oxford University Press, 2021. http://dx.doi.org/10.1093/oso/9780190078621.003.0004.

Der volle Inhalt der Quelle
Annotation:
No disease strikes more fear than cancer and none is more resistant to medical progress. This chapter illuminates the weaknesses of a health care system driven by profit rather than human need in addressing cancer. It explains how modern capitalism has undermined progress in cancer prevention and treatment. Reducing tobacco smoking has succeeded in reducing cancer, but pharmaceutical and other industries have not emphasized this approach because it is not profitable. Instead, they develop precision medicines, high intensity radiation, and private equity-financed high-tech oncology centers. While these have helped some patients, they have made cancer care exorbitantly expensive, out of reach of many Americans, and bankrupted those who can afford them. In response, cancer patients and their families, oncologists and other providers, and public officials are demanding a new approach to cancer, one that puts less emphasis on profitable drugs and devices and more on integrated prevention, early intervention, and affordable treatment approaches.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Marotti, Lorenza, Luigi Cataliotti und Robert Mansel. „EUSOMA“. In Breast cancer: Global quality care, herausgegeben von Didier Verhoeven, Sabine Siesling und Lee Tucker, 35–39. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198839248.003.0004.

Der volle Inhalt der Quelle
Annotation:
Abstract: The European Society of Breast Cancer Specialists (EUSOMA) is the only European multidisciplinary society dedicated to breast cancer. EUSOMA has defined the requirements for a Breast Centre. Basic requirements are: at least 150 new breast cancer cases per year, provision of all services necessary from genetics and prevention, through diagnosis and treatment of primary tumour, follow-up, care of advanced disease, and palliation. The Breast Centre must have a dedicated team of specialists who regularly meet in the multidisciplinary meeting. EUSOMA also defined a set of Quality Indicators (QIs) to allow standardized auditing and quality assurance. EUSOMA developed a voluntary certification process to evaluate Breast Centre compliance with EUSOMA requirements and QIs. This process has now become an accredited scheme run by a dedicated organization (www.breastcentrescertification.com). The Breast Centre certification scheme is focused on real data, essential clinical skills, structure, and procedure, aiming at improving the quality of care. Breast Centres undergoing certification send data to the EUSOMA data warehouse. The EUSOMA data centre performs an analysis and issues a report showing the performances of the selected EUSOMA QIs. Thanks to the availability of these data, Certified Breast Centres under the umbrella of EUSOMA collectively publish scientific papers on selected topics.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Shastri, Surendra, und Aditi Shastri. „Cancer Screening and Prevention in India“. In Textbook of Chronic Noncommunicable Diseases: The Health Challenge of 21st Century, 94. Jaypee Brothers Medical Publishers (P) Ltd., 2016. http://dx.doi.org/10.5005/jp/books/12691_8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Cancer prevention center"

1

Adams-Campbell, Lucile, Kepher Makambi, Wayne Frederick und Worta McCaskill -Stevens. „Abstract A58: Breast cancer risk estimates from the CARE and GAIL models among black women: Howard University Cancer Center experience“. In Abstracts: Frontiers in Cancer Prevention Research 2008. American Association for Cancer Research, 2008. http://dx.doi.org/10.1158/1940-6207.prev-08-a58.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Leifert, Jens A., Cornelia Schulz, Andreas Jaehne, Mirjam Elze, James Balmford und Oliver Opitz. „Abstract B17: A novel cancer prevention management strategy at the Comprehensive Cancer Center Freiburg (CCCF), Germany“. In Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Nov 7-10, 2010; Philadelphia, PA. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1940-6207.prev-10-b17.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Jethwa, Krishan, Brooke Settergren, Brittany Berg und James Beal. „Abstract B15: Association between travel distance to a comprehensive cancer center and breast cancer stage, treatment, and outcomes in a rural state“. In Abstracts: Twelfth Annual AACR International Conference on Frontiers in Cancer Prevention Research; Oct 27-30, 2013; National Harbor, MD. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1940-6215.prev-13-b15.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Asuncion, Bernadette R. „Abstract A136: Immunohistologic and clinicopathologic profile of thymic epithelial tumors: A 30‐year experience in the Philippine Heart Center“. In Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Dec 6–9, 2009; Houston, TX. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1940-6207.prev-09-a136.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Greenwald, Holly S., Chiranjeev Dash, Bridget Oppong, Tesha Coleman, Vivian Watkins und Lucile L. Adams-Campbell. „Abstract C06: Temporal changes in characteristics of women receiving screening mammograms at a community-based breast cancer screening center“. In Abstracts: Twelfth Annual AACR International Conference on Frontiers in Cancer Prevention Research; Oct 27-30, 2013; National Harbor, MD. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1940-6215.prev-13-c06.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Suzuki, Sho, Siew Ng, Takahisa Furuta, Takuji Gotoda, Kazuma Fujimoto und Francis KL Chan. „IDDF2019-ABS-0132 Metachronous gastric cancer prevention with aspirin after endoscopic submucosal dissection for early gastric cancer: protocol of a multi-center randomized controlled trial“. In International Digestive Disease Forum (IDDF) 2019, Hong Kong, 8–9 June 2019. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2019. http://dx.doi.org/10.1136/gutjnl-2019-iddfabstracts.7.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Reimers, LL, J. Campbell, D. Hershman, H. Greenlee, MB Terry, M. Maurer, K. Kalinsky et al. „P4-11-06: Uptake of Selective Estrogen Receptor Modulators and Other Breast Cancer Prevention Strategies among High-Risk Women Seen in a Breast Center.“ In Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/0008-5472.sabcs11-p4-11-06.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Hernandez, RE, R. Gerson, G. Olivares, S. Rivera, A. Serrano, A. Villalobos und M. Lazaro. „Abstract P5-11-13: Experience in the ABC Medical Center of Mexico City 2010-2015 using scalp-cooling system (DigniCap) for prevention of alopecia induced by chemotherapy“. In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-p5-11-13.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Rozmarinová, Jana. „The geographic concentration of cancer cases and the centers of its prevention“. In XXII. mezinárodní kolokvium o regionálních vědách. Brno: Masarykova univerzita, 2019. http://dx.doi.org/10.5817/cz.muni.p210-9268-2019-90.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Clark, Stephen, Daniel Reuland, Chineme Enyioha und Daniel Jonas. „8 How often do academic and community medical centers in the united states convey overdiagnosis on lung cancer screening websites compared to benefits and other harms?“ In Preventing Overdiagnosis Abstracts, December 2019, Sydney, Australia. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/bmjebm-2019-pod.22.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Berichte der Organisationen zum Thema "Cancer prevention center"

1

Gindi, Renee. Health, United States, 2019. Centers for Disease Control and Prevention (U.S.), 2021. http://dx.doi.org/10.15620/cdc:100685.

Der volle Inhalt der Quelle
Annotation:
Health, United States, 2019 is the 43rd report on the health status of the nation and is submitted by the Secretary of the Department of Health and Human Services to the President and the Congress of the United States in compliance with Section 308 of the Public Health Service Act. This report was compiled by the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC). The Health, United States series presents an annual overview of national trends in key health indicators. The 2019 report presents trends and current information on selected measures of morbidity, mortality, health care utilization and access, health risk factors, prevention, health insurance, and personal health care expenditures in a 20-figure chartbook. The Health, United States, 2019 Chartbook is supplemented by several other products including Trend Tables, an At-a-Glance table, and Appendixes available for download on the Health, United States website at: https://www.cdc.gov/nchs/hus/ index.htm. The Health, United States, 2019 Chartbook contains 20 figures and 20 tables on health and health care in the United States. Examining trends in health informs the development, implementation, and evaluation of health policies and programs. The first section (Figures 1–13) focuses on health status and determinants: life expectancy, infant mortality, selected causes of death, overdose deaths, suicide, maternal mortality, teen births, preterm births, use of tobacco products, asthma, hypertension, heart disease and cancer, and functional limitations. The second section (Figures 14–15) presents trends in health care utilization: use of mammography and colorectal tests and unmet medical needs. The third section (Figures 16–17) focuses on health care resources: availability of physicians and dentists. The fourth section (Figures 18–20) describes trends in personal health care expenditures, health insurance coverage, and supplemental insurance coverage among Medicare beneficiaries. The Highlights section summarizes major findings from the Chartbook. Suggested citation: National Center for Health Statistics. Health, United States, 2019. Hyattsville, MD. 2021.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Die Auswahlen zum Thema "Cancer prevention center" für konkrete Quellenarten können Sie auch interessieren:
Zeitschriftenartikel Bücher
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie